AMGEN Insider Trades
AMGN
Amgen Inc. (AMGN) is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, specializing in the discovery, development, manufacturing, and delivery of innovative human therapeutics for serious illnesses across areas like oncology, inflammation, bone health, cardiovascular disease, nephrology, and neuroscience. Key executives include Robert A. Bradway, who serves as Chairman and Chief Executive Officer, Peter H. Griffith as Executive Vice President and Chief Financial Officer, and David M. Reese as Executive Vice President and Chief Technology Officer. Directors on the board include Wanda M. Austin, Michael V. Drake, and Charles M. Holley, Jr. Insider trading activity at Amgen generally shows that insiders, including executives and directors, tend to engage in selling company stock more often than buying, with a net selling trend observed over various periods.